Saku App
Saku Terminal • $REGNLive $REGN AI Target, Catalysts & Support Levels
OPEN
Saku Logo
Saku
Back to Saku Market Terminal
Climate: STORMY
Updated Nov 22, 2026
Saku AI Market Briefing • $REGN (Regeneron Pharmaceuticals)

$REGN (Regeneron Pharmaceuticals) Support & Resistance Levels, AI Price Target & Institutional Flow.

Today, $REGN (Regeneron Pharmaceuticals) trades at $920.69 (-0.19%) with a 35/100 Momentum Pulse (STORMY) and 14D RSI at 40.3 (PULLBACK ZONE (40.3)). Unlock the live $REGN support and resistance levels, 30D Put Wall floor, 20D SMA pivot, Call Wall ceiling, dark pool flow, and locked 1-Month AI Price Target (+14.2% upside corridor) below—or create a free 24/7 AI quant agent to guard $REGN.

Saku AI Synthesis • Why Is $REGN Moving?
30D Support$752.35
30D Resistance$972.37
20-Day SMA$912.02
14-Day RSI40.3

Regeneron Pharmaceuticals (REGN) is down today following the announcement of multiple class-action lawsuits filed on August 11, 2026, alleging securities fraud related to misleading statements about its failed Phase III Fianlimab-Libtayo Study.

LIVE TERMINAL TELEMETRY
$920.69-0.19%
BEARISH PRESSURE
$REGN 30-DAY PRICE ACTION • STORMYUpdated Nov 22, 2026
$REGN Momentum Pulse (1–100)35/100
Fundamental Health Score45/100
Assign Ronin to Guard $REGN 24/7
3x/Day Shift Briefs & 24/7 Stop-Loss Sentinel
+ GUARD
Locked 1-Month AI Target:$1051.43 (+14.2%)Unlock Free →
Open Interactive $REGN Chart & Ask @Saku
Institutional Quantitative & Fundamental Telemetry

$REGN (Regeneron Pharmaceuticals) Live Key Levels, RSI & Valuation Matrix

Updated Nov 22, 2026
$REGN Technical MetricLive Value$REGN Fundamental / Regime MetricLive Status
Live Spot Price (24h Change)$920.69 (-0.19%)Market CapitalizationTracked in Terminal
30-Day Mechanical Support Floor (Put Wall)$752.35 (18.28% cushion)52-Week High / Low Range$591.52 – $991.73
20-Day Simple Moving Average (20D SMA)$912.02Trailing P/E Ratio & Dividend YieldGrowth / N/A • Yield: 0.41%
10-Day Exponential Moving Average (10D EMA)$935.02Average Daily Volume (Liquidity)843.6K shares
30-Day Resistance Ceiling (Call Wall)$972.37 (5.61% upside to test)Next Scheduled Earnings / Catalyst Window2026-10-30
14-Day Relative Strength Index (RSI)PULLBACK ZONE (40.3)Saku Momentum Pulse & Health Rating35/100 Momentum • 45/100 Health
Want live sub-second candlesticks, 20D SMA / 50D EMA overlays, and real-time Support & Resistance alerts on $REGN?Launch Interactive $REGN Chart
Saku AI Bull vs. Bear Breakdown

Should You Buy $REGN Stock Now or Wait?

$REGN Bull CaseUPSIDE DRIVERS

Regeneron's strong pipeline and existing successful drugs offer long-term growth potential despite current legal challenges.

Momentum Pulse: 35/100 (STORMY)Predict Bull Target
$REGN Bear Case & RisksRISK FACTORS

The ongoing class-action lawsuits and past failure of the Phase III Fianlimab-Libtayo Study could lead to significant financial penalties and reputational damage.

Fundamental Health: 45/100 ScoreAudit Downside Risk
Technicals, Volume & Catalysts

$REGN Support & Resistance, Institutional Flow & Catalysts.

Key Price Zones

$REGN Support & Resistance

Spot Price: $920.69 | 30-Day Support Floor: $752.35 (18.28% above) | 10-Day EMA: $935.02 | 20-Day SMA Pivot: $912.02 | 30-Day Resistance Ceiling: $972.37 (5.61% below) | 14-Day RSI: 40.3 (PULLBACK ZONE (40.3)) | 30-Day Trading Corridor: 29.24% span. AI Desk Note: Immediate support is near today's low of $773.82, while immediate resistance is around today's high of $809.02.

Chart IndicatorsSMA • EMA • RSI
Volume & Options Activity

$REGN Institutional & Whale Flow

Whale flow data for today's specific movement is not immediately discernible from public news or SEC filings, though institutional investors collectively hold a significant portion of the stock.

Saku Pro Deep-DiveTRACKED
Upcoming Events

$REGN Catalyst Outlook

The next specific event to watch is the lead plaintiff deadline for the class-action lawsuit on September 14, 2026.

Asset & Corporate Profile

About Regeneron Pharmaceuticals ($REGN)

Regeneron Pharmaceuticals ($REGN) is an actively traded institutional asset tracked inside the Saku AI Terminal.

Saku's quantitative engine continuously monitors $REGN's 30-day mechanical support floor ($752.35), 20-day simple moving average ($912.02), and 30-day resistance ceiling ($972.37) alongside off-exchange dark pool block prints and SEC filings.

Market CapTracked Live
5-Day Velocity-3.54%
52-Week Range$591.52 – $991.73
Avg Daily Vol843.6K shares
Inspect Full $REGN Fundamentals in Terminal
3D Agent Sanctuary • Workstation #4🔥 Early Adopter Lock-In (First 500 Desks)🎁 Code LINKEDIN: 30 Days Pro Free

Hatch Your Own 24/7 AI Co-Pilot to Guard $REGN.

Step inside the 3D Quant Sanctuary and claim Workstation #4 to hatch your personal AI analyst (Momentum, Dip-Buyer, or Value & Catalyst style). Your agent monitors $REGN 24/7 with locked 1-month price targets, hard stop-loss tripwires, 3x/day shift briefings, and live Koi Bridge debates.

Unlock all 4 Autonomous Quant Agents & 24/7 Stop-Loss Guard:$29/mo$14.99/mo(or $8.33/mo annual • Early Adopter Rate + 30 Days Free w/ code LINKEDIN)
app.sakustocks.com • Live $REGN Terminal & Agent Sanctuary
Launch Full Terminal
Saku Institutional AI Terminal analyzing $REGN (Regeneron Pharmaceuticals)
“Ask @Saku or Ronin: Would you buy $REGN right now or wait for a pullback?”
5 Guard Slots • 50 Daily @Saku Queries
Frequently Asked Questions About $REGN

What are the live 30-day support and resistance levels for $REGN (Regeneron Pharmaceuticals)?

Spot Price: $920.69 | 30-Day Support Floor: $752.35 (18.28% above) | 10-Day EMA: $935.02 | 20-Day SMA Pivot: $912.02 | 30-Day Resistance Ceiling: $972.37 (5.61% below) | 14-Day RSI: 40.3 (PULLBACK ZONE (40.3)) | 30-Day Trading Corridor: 29.24% span. AI Desk Note: Immediate support is near today's low of $773.82, while immediate resistance is around today's high of $809.02. $REGN currently registers a Saku Momentum Pulse score of 35/100 and a Fundamental Health score of 45/100.

Why is $REGN (Regeneron Pharmaceuticals) moving and what is the bull vs. bear thesis?

Bull Thesis: Regeneron's strong pipeline and existing successful drugs offer long-term growth potential despite current legal challenges. Bear Thesis: The ongoing class-action lawsuits and past failure of the Phase III Fianlimab-Libtayo Study could lead to significant financial penalties and reputational damage.

What are $REGN's key fundamentals, 52-week range, and upcoming catalysts?

Regeneron Pharmaceuticals ($REGN) trades with a market cap of tracked institutional scale, and a 52-week range of $591.52 to $991.73. The next specific event to watch is the lead plaintiff deadline for the class-action lawsuit on September 14, 2026.

Saku Tracked Assets

Explore More AI Stock & Crypto Quant Dossiers

View 14-Day Catalyst Calendar →

© 2026 Saku Financial Inc. Saku™ is a trademark of Saku Financial Inc.